Physician profile
Ty Swartzlander
NPI 1366670705
$2,184.91
in general payments reported to CMS, 2019-2025
24 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $219 · 2021: $337 · 2022: $636 · 2023: $384 · 2024: $177 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833 · Education: $19.27 · Gift: $9.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.15 |
| Education | $19.27 |
| Gift | $9.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $438.75 | 2022 | |
| Coopersurgical, INC. | $322.95 | 2020-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $322.04 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $187.09 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $152.02 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $119.48 | 2023 | |
| Exeltis, USA INC. | $100.76 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $96.31 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.17 | 2022-2025 | |
| Pfizer INC. | $58.67 | 2023-2024 | |
| Zyla Life Sciences, INC. | $46.93 | 2020 | |
| Lupin INC. | $36.96 | 2020-2021 | |
| Scynexis, INC. | $32.09 | 2022 | |
| Agile Therapeutics, INC. | $27.87 | 2021-2024 | Twirla |
| Meditrina | $27.77 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.77 | 2024 | Wegovy |
| Mission Pharmacal Company | $22.75 | 2020 | |
| Vertical Pharmaceuticals, LLC | $22.20 | 2019 | |
| Millicent US INC | $17.98 | 2025 | Intrarosa, Femlyv |
| Myovant Sciences INC. | $16.21 | 2021 | |
| Allergan, INC. | $15.38 | 2019 | |
| Merz North America, INC. | $14.41 | 2021 | |
| Avion Pharmaceuticals | $13.63 | 2021 | |
| Intuitive Surgical, INC. | $9.72 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ty Swartzlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.